相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The dual role of mesenchymal stem cells in tumor progression
Celia Maria Freitas Gomes
STEM CELL RESEARCH & THERAPY (2013)
The dual effect of mscs on tumour growth and tumour angiogenesis
Michelle Keramidas et al.
STEM CELL RESEARCH & THERAPY (2013)
The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells
Yi Ma et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin
G. Garcia-Santos et al.
BRITISH JOURNAL OF CANCER (2012)
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells
Sabino Ciavarella et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Bioactivity and Prognostic Significance of Growth Differentiation Factor GDF15 Secreted by Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma
Jill Corre et al.
CANCER RESEARCH (2012)
Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis
Kentaro Akiyama et al.
CELL STEM CELL (2012)
Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growth
Xin Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Mesenchymal Stem Cell 1 (MSC1)-Based Therapy Attenuates Tumor Growth Whereas MSC2-Treatment Promotes Tumor Growth and Metastasis
Ruth S. Waterman et al.
PLOS ONE (2012)
Effects of the Fas/Fas-L Pathway on Fluoride-Induced Apoptosis in SH-SY5Y Cells
Bayi Xu et al.
ENVIRONMENTAL TOXICOLOGY (2011)
A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function
S. Vallet et al.
LEUKEMIA (2011)
Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α
Yi Liu et al.
NATURE MEDICINE (2011)
Both human and mouse mesenchymal stem cells promote breast cancer metastasis
Stella Maris Albarenque et al.
STEM CELL RESEARCH (2011)
Human Placenta-Derived Adherent Cells Prevent Bone loss, Stimulate Bone formation, and Suppress Growth of Multiple Myeloma in Bone
Xin Li et al.
STEM CELLS (2011)
Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?
Ann H. Klopp et al.
STEM CELLS (2011)
Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma
Lijuan Chen et al.
BLOOD (2010)
Advances in the understanding of myeloma bone disease and tumour growth
Shmuel Yaccoby
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Mesenchymal stem cells enhance growth and metastasis of colon cancer
Kei Shinagawa et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Survivin is upregulated in myeloma cell lines cocultured with mesenchymal stem cells
Xiaofang Wang et al.
LEUKEMIA RESEARCH (2010)
The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth
Angela Pennisi et al.
BLOOD (2009)
Osteogenic differentiation of mesenchymal stem cells in multiple myeloma: Identification of potential therapeutic targets
Nicola Giuliani et al.
EXPERIMENTAL HEMATOLOGY (2009)
The Many Roles of FAS Receptor Signaling in the Immune System
Andreas Strasser et al.
IMMUNITY (2009)
Cytotoxicity Mediated by the Fas Ligand (FasL)-activated Apoptotic Pathway in Stem Cells
Julia Mazar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Mesenchymal Stem Cells Derived from Human Gingiva Are Capable of Immunomodulatory Functions and Ameliorate Inflammation-Related Tissue Destruction in Experimental Colitis
Qunzhou Zhang et al.
JOURNAL OF IMMUNOLOGY (2009)
Repair of Tissues by Adult Stem/Progenitor Cells (MSCs): Controversies, Myths, and Changing Paradigms
Darwin J. Prockop
MOLECULAR THERAPY (2009)
The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells
Seth B. Coffelt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Role of decorin in the antimyeloma effects of osteoblasts
Xin Li et al.
BLOOD (2008)
Storage, expression and function of fas ligand, the key death factor of immune cells
Marcus Lettau et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Placental-derived and expanded mesenchymal stromal cells (PLX-I) to enhance the engraftment of hematopoietic stem cells derived from umbilical cord blood
William R. Prather et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells
Biju Parekkadan et al.
STEM CELLS (2008)
Mesenchymal stem cells in health and disease
Antonio Uccelli et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Refractory multiple myeloma treated with homoharringtonine: report of two cases
Xiudi Yang et al.
ANNALS OF HEMATOLOGY (2007)
Abnormal surface markers expression on bone marrow CD34+ cells and correlation with disease activity in patients with systemic lupus erythematosus
Ling-Yun Sun et al.
CLINICAL RHEUMATOLOGY (2007)
The role of the bone marrow microenvironment in the pathophysiology of myeloma and its significance in the development of more effective therapies
Constantine S. Mitsiades et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2007)
The CD95 receptor: Apoptosis revisited
Marcus E. Peter et al.
CELL (2007)
Magnetic resonance imaging in multiple myeloma: Diagnostic and clinical implications
Ronald Walker et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo
Shmuel Yaccoby et al.
BLOOD (2007)
Homoharringtonine induces apoptosis and growth arrest in human myeloma cells
Yin-Jun Lou et al.
LEUKEMIA & LYMPHOMA (2007)
Melphalan: old and new uses of a still master drug for multiple myeloma
Pellegrino Musto et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Multiple myeloma bone disease: pathophysiology of osteoblast inhibition
Nicola Giuliani et al.
BLOOD (2006)
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Aarif Y. Khakoo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: A potential role in the development of lytic bone disease and tumor progression in multiple myeloma
William G. Gunn et al.
STEM CELLS (2006)
Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2
T Oshima et al.
BLOOD (2005)
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation
N Giuliani et al.
BLOOD (2005)
Molecular pathogenesis and a consequent classification of multiple myeloma
PL Bergsagel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy
E Zappia et al.
BLOOD (2005)
Dual effects of macrophage inflammatory protein-1α on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease
BO Oyajobi et al.
BLOOD (2003)
The association of blood lead level and cancer mortality among whites in the United States
A Jemal et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2002)
分享论文
